Chinese wholesalers produce quality products elisa kits hbcab

Bioneovan HBcAb ELISA Kit is an in vitro enzyme linked immunoassay supplied for the detection of HBcAb in human serum or plasma. It is intended for use in clinical laboratories for diagnosis and management of patients related to infection with hepatitis B virus. 1. Micropipettes: 0.02, 0.05, 0.10, 0.15, 0.20, and 1.0 ml.
2. Disposable pipette tips.
3. Distilled or deionized water.
4. Humidified Box capable of maintaining 37°C
5. Absorbent paper or paper towel.
6. Micro titer plate or strip-well washer
7. Micro titer plate reader with 450nm (or 450 nm/630 nm) wavelength
8. Timer Blood serum samples are routinely prepared form vein. Blood plasma samples are routinely prepared with routine amount of anticoagulant such as heparin or sodium citrate. Sample can be stored at 4°C if tested within two days. Specimens not required within 3 days should be stored at -20°C. Avoid hemolysis and repetitive freeze and thaw of samples. Samples with cloud or precipitation should be centrifugated or filtered before test. Prevent serum from bacterium contamination during collecting and storing. 1. Non-repeatable positive result may occur due to the general biological and biochemical characteristics of the ELISA method. The test is designed to achieve very high performance characteristics of sensitivity and specificity. However, in very rare cases some HBV mutants or subtypes can remain undetectable. Antibodies may be also undetectable during the early stages of the disease and in some immunosuppressed individuals.
2. Any positive results must be interpreted in conjunction with patient clinical information and other laboratory testing results.
3. This is a qualitative assay and the results cannot be used to measure antibodies concentrations.
4. If, after retesting of the initially reactive samples, the assay results are negative, these samples should be considered as non-repeatable (false positive) and interpreted as negative. As with many very sensitive ELISA assays, false positive results can occur due to the several reasons, most of which are related but not limited to inadequate washing step.
5. A negative test result at any point in the investigation of individual subjects does not preclude the possibility of exposure to or infection with HBV.
Company Profile
Beijing Huan Biotechnology Co., Ltd. BRIC in 2005 by Beijing Sihuan Pharmaceutical Co., Ltd. [listed company, Jiangsu Sihuan Bioengineering Co., a subsidiary] from discrete reorganization, was originally a subsidiary company of Military Medical Sciences; beginning built in 1988, is the earliest in genetic engineering drugs and diagnostics research, test, production and sales of high-tech enterprises.

2005 in Beijing Daxing Industrial Development Zone Overseas Students Pioneer Park built a 1500 square meters of in vitro diagnostic reagents standard production workshop, 2008 has passed GMP certification, the Certificate of GMP, and through ELISA, gold standard quality management system assessment. In 2009 the company obtained the ISO9001: 2008 quality management system certification. All work to achieve standardized management.

The company has research and development department, quality control department, production department, marketing department, comprehensive department, logistics, warehousing, Personnel Administration Department, General Manager's Office, etc.; business managers experienced, proficient in the medical profession; company established through the introduction and cultivation of talents of a high-quality management, research and development, engineering, quality control, production, marketing and administrative professionals, formed a strict and comprehensive production quality management system.

Enterprises and Chinese Military Academy of Medical Sciences signed a long-term technical cooperation agreement with the Chinese Academy of Sciences and other domestic research institutes to establish a close contact. Employ a number of medicine, biology became a biomedical expert committee of experts, relying on these forces and our unremitting efforts, the company will continue to introduce new bio-medicine, service to society